Uri Geiger - Sep 19, 2025 Form 4 Insider Report for NeuroPace Inc (NPCE)

Role
Director
Signature
/s/ Leah Akin, Attorney-in-Fact
Stock symbol
NPCE
Transactions as of
Sep 19, 2025
Transactions value $
$11,868
Form type
4
Date filed
9/22/2025, 07:30 PM
Previous filing
Jun 9, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Geiger Uri Director C/O NEUROPACE, INC., 455 N. BERNARDO AVENUE, MOUNTAIN VIEW /s/ Leah Akin, Attorney-in-Fact 2025-09-22 0001467361

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NPCE Common Stock Award $11.9K +1.19K +9.92% $9.94 13.2K Sep 19, 2025 Direct F1
holding NPCE Common Stock 4.43M Sep 19, 2025 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees.
F2 Shares are held by Accelmed Partners II LP. Accelmed Partners II, LLC ("Accelmed LLC") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. The Reporting Person is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP.